[Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]
- PMID: 1834610
[Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]
Abstract
Glucocorticosteroids are among the most useful and most widely prescribed anti-inflammatory drugs. Despite their wide use little is yet known about their mode of action. In the last 10 years a group of proteins called lipocortins or annexins has been characterized. Those proteins exert an inhibitory effect on the synthesis of lipid mediators by way of an important proinflammatory enzyme, phospholipase A2. Phospholipases are known to be involved in cell-signal transduction and generation of inflammatory mediators like prostaglandins, leukotrienes and platelet-activating-factor. The cellular expression of lipocortins is induced by glucocorticosteroids. The inhibition of cellular phospholipases via lipocortins may account for some aspects of the action of glucocorticosteroids.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical